XML 68 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900
Equity
12 Months Ended
Dec. 31, 2015
Stockholders' Equity Note [Abstract]  
Shareholders' Equity
EQUITY

Ordinary Shares
The reconciliation of Ordinary shares is as follows:
In millions
Total
December 31, 2014
95.8

Shares issued under incentive plans
0.7

Repurchase of ordinary shares
(0.5
)
December 31, 2015
96.0


Allegion had 400.0 million ordinary shares authorized and 10.0 million $0.001 par value preferred shares authorized (with none outstanding) at December 31, 2015. During the year ended December 31, 2015, the Company paid $30.0 million to repurchase 0.5 million ordinary shares on the open market under a share repurchase program previously approved by its Board of Directors.

Other Comprehensive Income (Loss)

The changes in Accumulated other comprehensive income (loss) are as follows:
In millions
 
Cash flow hedges and marketable securities
 
Pension and OPEB Items
 
Foreign Currency Items
 
Total
December 31, 2012
 
$
10.9

 
$
(95.7
)
 
$
77.1

 
$
(7.7
)
Other comprehensive income (loss), net of tax
 
5.8

 
(35.6
)
 
(59.2
)
 
(89.0
)
December 31, 2013
 
$
16.7

 
$
(131.3
)
 
$
17.9

 
$
(96.7
)
Other comprehensive income (loss), net of tax
 
(1.0
)
 
15.2

 
(65.7
)
 
(51.5
)
December 31, 2014
 
$
15.7

 
$
(116.1
)
 
$
(47.8
)
 
$
(148.2
)
Other comprehensive income (loss), net of tax
 
(1.7
)
 
(23.2
)
 
(59.1
)
 
(84.0
)
December 31, 2015
 
$
14.0

 
$
(139.3
)
 
$
(106.9
)
 
$
(232.2
)


The amounts of Other comprehensive income (loss) attributable to noncontrolling interests are as follows:
In millions
 
2015
 
2014
 
2013
Foreign currency items
 
$
(1.4
)
 
$
(0.7
)
 
$
0.8

Total other comprehensive income (loss) attributable to noncontrolling interests
 
$
(1.4
)
 
$
(0.7
)
 
$
0.8



Included in equity for the year ended December 31, 2014 were $13.0 million of adjustments related to the completion of the allocation of taxable income and the completion of the allocation of tax basis in certain assets between Ingersoll Rand and Allegion at the Spin-off.